These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11017110)

  • 21. A stress sensitive ER membrane-association domain in Huntingtin protein defines a potential role for Huntingtin in the regulation of autophagy.
    Atwal RS; Truant R
    Autophagy; 2008 Jan; 4(1):91-3. PubMed ID: 17986868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huntingtin in health and disease.
    Young AB
    J Clin Invest; 2003 Feb; 111(3):299-302. PubMed ID: 12569151
    [No Abstract]   [Full Text] [Related]  

  • 23. Huntington disease and the huntingtin protein.
    Zheng Z; Diamond MI
    Prog Mol Biol Transl Sci; 2012; 107():189-214. PubMed ID: 22482451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug targeting of dysregulated transcription in Huntington's disease.
    Kazantsev AG; Hersch SM
    Prog Neurobiol; 2007 Nov; 83(4):249-59. PubMed ID: 17379386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's disease.
    Miller TW; Zhou C; Gines S; MacDonald ME; Mazarakis ND; Bates GP; Huston JS; Messer A
    Neurobiol Dis; 2005; 19(1-2):47-56. PubMed ID: 15837560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH; Li XJ
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits.
    Aharony I; Ehrnhoefer DE; Shruster A; Qiu X; Franciosi S; Hayden MR; Offen D
    Hum Mol Genet; 2015 May; 24(9):2604-14. PubMed ID: 25616965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo models for Huntington disease: lessons for the polyglutamine expansion disorders.
    Hayden MR
    Pathol Biol (Paris); 1998 Nov; 46(9):695-6. PubMed ID: 9885820
    [No Abstract]   [Full Text] [Related]  

  • 29. Polyglutamine expansion and Huntington's disease.
    Bates GP; Mangiarini L; Wanker EE; Davies SW
    Biochem Soc Trans; 1998 Aug; 26(3):471-5. PubMed ID: 9765898
    [No Abstract]   [Full Text] [Related]  

  • 30. The HD mutation does not alter neuronal death in the striatum of Hdh(Q92) knock-in mice after mild focal ischemia.
    Namura S; Hirt L; Wheeler VC; McGinnis KM; Hilditch-Maguire P; Moskowitz MA; MacDonald ME; Persichetti F
    Neurobiol Dis; 2002 Oct; 11(1):147-54. PubMed ID: 12460554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scientists scope out Huntington disease.
    Hampton T
    JAMA; 2005 Jan; 293(1):29. PubMed ID: 15632323
    [No Abstract]   [Full Text] [Related]  

  • 32. The enigma of Huntington's disease.
    Cattaneo E; Rigamonti D; Zuccato C
    Sci Am; 2002 Dec; 287(6):92-7. PubMed ID: 12469651
    [No Abstract]   [Full Text] [Related]  

  • 33. Normal and mutant huntingtin: partners in crime.
    Di Prospero NA; Tagle DA
    Nat Med; 2000 Nov; 6(11):1208-9. PubMed ID: 11062523
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurodegeneration. Huntington's research points to possible new therapies.
    Marx J
    Science; 2005 Oct; 310(5745):43-5. PubMed ID: 16210515
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro expression systems for the Huntington protein.
    Li SH; Li XJ
    Methods Mol Biol; 2003; 217():277-84. PubMed ID: 12491940
    [No Abstract]   [Full Text] [Related]  

  • 36. Aggregation inhibitors: hope for Huntington's?
    Sansom C
    Mol Med Today; 1999 Sep; 5(9):372. PubMed ID: 10462746
    [No Abstract]   [Full Text] [Related]  

  • 37. Hunting in the calm before the storm.
    Bates G; Eberwine J
    Nat Genet; 2000 Aug; 25(4):365-6. PubMed ID: 10932169
    [No Abstract]   [Full Text] [Related]  

  • 38. [Huntington disease].
    Nukina N
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1139-40. PubMed ID: 9577671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hunting down huntingtin.
    Aronin N; Moore M
    N Engl J Med; 2012 Nov; 367(18):1753-4. PubMed ID: 23113488
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct amplification of the CAG repeat of huntingtin without amplification of CCG.
    Bond CE; Hodes ME
    Clin Chem; 1996 May; 42(5):773-4. PubMed ID: 8653908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.